Literature DB >> 6605358

Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders.

N Tomori, T Suda, F Tozawa, H Demura, K Shizume, T Mouri.   

Abstract

The concentrations of immunoreactive corticotropin-releasing factor (I-CRF) in human cerebrospinal fluid (CSF) were measured utilizing immunoaffinity chromatography and RIA in patients with no endocrine disease, patients with Cushing's disease, Nelson's syndrome, Sheehan's syndrome, Addison's disease and steroid treated patients. On high performance liquid chromatography, the elution profile and retention time of I-CRF in CSF were not identical with ovine CRF. I-CRF concentrations in CSF from patients with Cushing's disease and Sheehan's syndrome were lower than those from normal subjects, however those from patients with Nelson's syndrome and Addison's disease were within the normal range. I-CRF concentrations in CSF from patients with Cushing's disease returned to normal levels 2-9 months after pituitary adenomectomy. These results suggest that CSF I-CRF concentrations are reduced by increased plasma corticosteroid levels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605358     DOI: 10.1210/jcem-57-6-1305

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Coexistence of hypothalamic and pituitary failure after successful pituitary surgery in Cushing's disease?

Authors:  A R Hermus; G F Pieters; G J Pesman; E Meijer; A G Smals; T J Benraad; P W Kloppenborg
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

2.  Corticotropin releasing hormone in plasma of patients with Cushing's disease.

Authors:  G K Stalla; J Stalla; K von Werder; O A Müller; D K Lüdecke; U Schrell; R Fahlbusch
Journal:  Klin Wochenschr       Date:  1987-06-01

3.  Endocrinological differentiation of primary hypothalamic and pituitary disease.

Authors:  E E Müller
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

4.  Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.

Authors:  A E Calogero; W T Gallucci; P W Gold; G P Chrousos
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

5.  Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism.

Authors:  P A van Wijk; A Rijnberk; R J Croughs; B P Meij; I S van Leeuwen; E P Sprang; J A Mol
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

6.  Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans.

Authors:  A Sasaki; O Shinkawa; K Yoshinaga
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Immunoreactive corticotropin-releasing factor in human plasma.

Authors:  T Suda; N Tomori; F Yajima; T Sumitomo; Y Nakagami; T Ushiyama; H Demura; K Shizume
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.